GLUE
Price
$5.06
Change
-$0.16 (-3.07%)
Updated
Apr 25 closing price
Capitalization
311.24M
11 days until earnings call
GUTS
Price
$1.26
Change
-$0.02 (-1.56%)
Updated
Apr 25 closing price
Capitalization
61.64M
22 days until earnings call
Ad is loading...

GLUE vs GUTS

Header iconGLUE vs GUTS Comparison
Open Charts GLUE vs GUTSBanner chart's image
Monte Rosa Therapeutics
Price$5.06
Change-$0.16 (-3.07%)
Volume$392.84K
Capitalization311.24M
Fractyl Health
Price$1.26
Change-$0.02 (-1.56%)
Volume$143.9K
Capitalization61.64M
GLUE vs GUTS Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. GUTS commentary
Apr 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and GUTS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 27, 2025
Stock price -- (GLUE: $5.06 vs. GUTS: $1.26)
Brand notoriety: GLUE and GUTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 50% vs. GUTS: 59%
Market capitalization -- GLUE: $311.24M vs. GUTS: $61.64M
GLUE [@Biotechnology] is valued at $311.24M. GUTS’s [@Biotechnology] market capitalization is $61.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $276.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileGUTS’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • GUTS’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while GUTS’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 6 bearish.
  • GUTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GUTS is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а +11.21% price change this week, while GUTS (@Biotechnology) price change was +3.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 07, 2025.

GUTS is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($311M) has a higher market cap than GUTS($61.6M). GLUE YTD gains are higher at: -27.089 vs. GUTS (-38.835). GUTS has higher annual earnings (EBITDA): -92.85M vs. GLUE (-121.07M). GLUE has more cash in the bank: 242M vs. GUTS (67.5M). GLUE has less debt than GUTS: GLUE (43.7M) vs GUTS (62.5M). GLUE has higher revenues than GUTS: GLUE (15M) vs GUTS (93K).
GLUEGUTSGLUE / GUTS
Capitalization311M61.6M505%
EBITDA-121.07M-92.85M130%
Gain YTD-27.089-38.83570%
P/E RatioN/AN/A-
Revenue15M93K16,129%
Total Cash242M67.5M359%
Total Debt43.7M62.5M70%
TECHNICAL ANALYSIS
Technical Analysis
GLUEGUTS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTHCX72.851.16
+1.62%
Fidelity Advisor Technology C
GLVNX72.400.72
+1.00%
Invesco Global Focus R
CMCCX13.030.08
+0.62%
Columbia Select Mid Cap Gro Fd C
BRZAX12.200.03
+0.25%
BlackRock Sus Adg Intl Eq Inv A
HTSCX9.05-0.06
-0.66%
Hartford Small Cap Value C

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with ATXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-3.07%
ATXS - GLUE
42%
Loosely correlated
-0.77%
IMNM - GLUE
40%
Loosely correlated
-1.41%
CRSP - GLUE
40%
Loosely correlated
-2.15%
KYMR - GLUE
39%
Loosely correlated
-0.89%
RXRX - GLUE
39%
Loosely correlated
-0.35%
More

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with IPSC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-1.56%
IPSC - GUTS
35%
Loosely correlated
-5.38%
PRME - GUTS
35%
Loosely correlated
-3.43%
GLUE - GUTS
34%
Loosely correlated
-3.07%
KYTX - GUTS
33%
Loosely correlated
-1.87%
CABA - GUTS
33%
Poorly correlated
N/A
More